Nation's Largest Renal Research Network Completes 13 Phase-I Clinical
Trials; Reports Another 34 Active Trials in Late Stage Development
EL SEGUNDO, Calif., May 8 /PRNewswire/ -- DaVita Clinical Research(R)
(DCR), a Phase I-IV clinical trial research service business specializing
in renal-related drug and device research and development for FDA approval,
reports it completed 13 Phase-I clinical trials in 2007 and has another 34
active trials in late stage drug development-a company record.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)
DCR(R), through its commitment to quality, timely and accurate clinical
trials, plays a valuable role by partnering with physicians, pharmaceutical
and biotechnology companies to develop and progress new drug therapies for
patients diagnosed with chronic kidney disease (CKD). The increase in
completed and late stage trials also serves as an indication of continued
innovation and investment for end stage renal disease (ESRD) research.
"The recent DaVita Clinical Research accomplishments can be attributed
to our continuous research quality index measurements and commitment to
service excellence," said Chris Rucker, DCR Vice President and General
Manager. "These values serve as a catalyst for our research objectives, and
allow us to participate in the advancement of renal knowledge and
practice."
DCR has nearly two decades of experience in conducting Phase I-IV
clinical trials, and is the nation's largest renal research network
dedicated to providing and supporting clinical and data research. DCR
provides Phase-I renal studies services including renal, Hepatic, CV,
Dermatology and Endocrine subjects, Pharmacokinetics, Pharmacodynamics and
drug interactions. Phase II- IV renal studies services include pre ESRD and
ESRD subjects, clinical efficacy and safety, special populations and post
marketing studies.
"Since departing full-time academics for private practice, DaVita
Clinical Research has helped me to continue my clinical research efforts,"
said Robert I. Lynn, M.D. of Nephrology & Hypertension Associates. "The
staff locates high quality studies and makes it easier to do clinical
trials in DaVita(R) facilities. They are friendly, responsive and
supportive, and DaVita Clinical Research really does work with you not only
to get a research effort 'off the ground,' but also to help it develop and
prosper."
DaVita and DaVita Clinical Research are registered trademarks of DaVita
Inc. All other trademarks are the properties of their respective owners.
About DaVita Inc.
DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney
care in the United States, providing dialysis services and education for
patients with chronic kidney failure and end stage renal disease. DaVita
manages more than 1,300 outpatient facilities and acute units in more than
700 hospitals located in 43 states and the District of Columbia, serving
approximately 107,000 patients. For more information about DaVita and its
kidney education programs, please visit http://www.davita.com.
SOURCE DaVita Clinical Research
 back to top
Related links:
http://www.davita.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Basak Ertan, 1-800-310-4872, for DaVita
Clinical Research
|
